BG105688A - Utilization of compounds for the prophylaxis and therapy of cerbral ischaemia - Google Patents
Utilization of compounds for the prophylaxis and therapy of cerbral ischaemiaInfo
- Publication number
- BG105688A BG105688A BG105688A BG10568801A BG105688A BG 105688 A BG105688 A BG 105688A BG 105688 A BG105688 A BG 105688A BG 10568801 A BG10568801 A BG 10568801A BG 105688 A BG105688 A BG 105688A
- Authority
- BG
- Bulgaria
- Prior art keywords
- prophylaxis
- therapy
- utilization
- compounds
- ischaemia
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 208000028867 ischemia Diseases 0.000 title 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19900544A DE19900544A1 (de) | 1999-01-11 | 1999-01-11 | Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie |
PCT/EP1999/010275 WO2000041697A1 (de) | 1999-01-11 | 1999-12-22 | Verwendung von 2-substituierten 1,2-benzisothiazol-derivaten und von 3-substituierten tetrahydropyridopyrimidinon-derivaten zur prophylaxe und therapie der zerebralen ischämie |
Publications (1)
Publication Number | Publication Date |
---|---|
BG105688A true BG105688A (en) | 2002-02-28 |
Family
ID=7893835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105688A BG105688A (en) | 1999-01-11 | 2001-07-10 | Utilization of compounds for the prophylaxis and therapy of cerbral ischaemia |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1140099A1 (no) |
JP (1) | JP2002534467A (no) |
KR (1) | KR20010101440A (no) |
CN (1) | CN1333685A (no) |
AR (1) | AR029741A1 (no) |
AU (1) | AU2285100A (no) |
BG (1) | BG105688A (no) |
BR (1) | BR9916888A (no) |
CA (1) | CA2359390A1 (no) |
DE (1) | DE19900544A1 (no) |
HU (1) | HUP0200520A3 (no) |
IL (1) | IL144145A0 (no) |
MX (1) | MXPA01006966A (no) |
NO (1) | NO20013408L (no) |
PL (1) | PL348916A1 (no) |
SK (1) | SK9682001A3 (no) |
TR (1) | TR200102009T2 (no) |
WO (1) | WO2000041697A1 (no) |
ZA (1) | ZA200105473B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4654035B2 (ja) | 2002-11-05 | 2011-03-16 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 抗菌剤 |
EP1667979A4 (en) * | 2003-09-23 | 2007-04-18 | Merck & Co Inc | INHIBITORS OF POTASSIUM CHANNELS WITH ISOQUINOLINE |
JP4324221B2 (ja) * | 2005-08-26 | 2009-09-02 | 株式会社医薬分子設計研究所 | Pparアゴニスト活性を有する誘導体 |
KR20100063087A (ko) * | 2007-09-20 | 2010-06-10 | 코텍스 파마슈티칼스, 인크. | 글루타메이트 시냅스 반응 향상을 위한 3-치환된 1,2,3-트리아진-4-온 및 3-치환된 1,3-피리미디논 |
MA41168A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
CN108484594B (zh) * | 2018-02-09 | 2020-08-04 | 福建医科大学 | 一种烷氧基取代四氢吡啶并嘧啶类化合物或其可用盐及其制备方法与应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3620643A1 (de) * | 1985-06-22 | 1987-01-22 | Sandoz Ag | Thiazole, ihre herstellung und verwendung |
DE3831888A1 (de) * | 1988-09-20 | 1990-03-29 | Troponwerke Gmbh & Co Kg | Arzneimittel zur behandlung von apoplexia cerebri |
JP3036789B2 (ja) * | 1990-06-22 | 2000-04-24 | 三井化学株式会社 | 新規な複素環式化合物及び医薬組成物 |
DE19746612A1 (de) * | 1997-10-22 | 1999-04-29 | Basf Ag | 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung |
DE19747063A1 (de) * | 1997-10-24 | 1999-04-29 | Basf Ag | 3-substituierte Tetrahydropyridopyrimidinon-Derivate, ihre Herstellung und Verwendung |
-
1999
- 1999-01-11 DE DE19900544A patent/DE19900544A1/de not_active Withdrawn
- 1999-12-22 PL PL99348916A patent/PL348916A1/xx not_active Application Discontinuation
- 1999-12-22 TR TR2001/02009T patent/TR200102009T2/xx unknown
- 1999-12-22 KR KR1020017008690A patent/KR20010101440A/ko not_active Application Discontinuation
- 1999-12-22 CN CN99815452A patent/CN1333685A/zh active Pending
- 1999-12-22 IL IL14414599A patent/IL144145A0/xx unknown
- 1999-12-22 WO PCT/EP1999/010275 patent/WO2000041697A1/de not_active Application Discontinuation
- 1999-12-22 CA CA002359390A patent/CA2359390A1/en not_active Abandoned
- 1999-12-22 EP EP99966990A patent/EP1140099A1/de not_active Withdrawn
- 1999-12-22 BR BR9916888-0A patent/BR9916888A/pt not_active IP Right Cessation
- 1999-12-22 SK SK968-2001A patent/SK9682001A3/sk unknown
- 1999-12-22 MX MXPA01006966A patent/MXPA01006966A/es unknown
- 1999-12-22 JP JP2000593308A patent/JP2002534467A/ja active Pending
- 1999-12-22 AU AU22851/00A patent/AU2285100A/en not_active Abandoned
- 1999-12-22 HU HU0200520A patent/HUP0200520A3/hu unknown
-
2000
- 2000-01-06 AR ARP000100036A patent/AR029741A1/es unknown
-
2001
- 2001-07-03 ZA ZA200105473A patent/ZA200105473B/xx unknown
- 2001-07-10 NO NO20013408A patent/NO20013408L/no not_active Application Discontinuation
- 2001-07-10 BG BG105688A patent/BG105688A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0200520A3 (en) | 2003-04-28 |
AU2285100A (en) | 2000-08-01 |
MXPA01006966A (es) | 2002-04-10 |
EP1140099A1 (de) | 2001-10-10 |
KR20010101440A (ko) | 2001-11-14 |
ZA200105473B (en) | 2002-10-03 |
NO20013408D0 (no) | 2001-07-10 |
PL348916A1 (en) | 2002-06-17 |
CN1333685A (zh) | 2002-01-30 |
TR200102009T2 (tr) | 2002-01-21 |
JP2002534467A (ja) | 2002-10-15 |
BR9916888A (pt) | 2001-11-20 |
WO2000041697A1 (de) | 2000-07-20 |
CA2359390A1 (en) | 2000-07-20 |
AR029741A1 (es) | 2003-07-16 |
HUP0200520A2 (hu) | 2002-07-29 |
NO20013408L (no) | 2001-08-21 |
IL144145A0 (en) | 2002-05-23 |
DE19900544A1 (de) | 2000-07-13 |
SK9682001A3 (en) | 2002-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY127126A (en) | Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation | |
MY128765A (en) | Novel benzoimidazole derivatives useful as antiproliferative agents. | |
PT1416935E (pt) | Derivados de 4-amino-6-fenil-pirrolo[2,3-d]pirimidina | |
CA2478374A1 (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
TW200518753A (en) | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents | |
BG106003A (en) | New n-cyanomethylamides and compositions as protease inhibitors | |
BG105515A (en) | Substituted 2-phenylbenzimidazoles, the production thereof and their use | |
PL361807A1 (en) | Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments | |
MY134222A (en) | NEW MEDICAMENT COMPOSITIONS BASED ON ANTICHOLINERGICALLY-EFFECTIVE COMPOUNDS AND ß-MIMETICS | |
MY115662A (en) | Novel compounds with analgesic effect | |
YU65804A (sh) | Nova heterociklična jedinjenja aktivna kao inhibitori beta-laktamaze | |
BG106343A (en) | Carboxylic acid amides, medicaments containing these compounds and the use and production thereof | |
MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
BG105689A (en) | Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia | |
BG108426A (en) | Novel sulfonic acid derivatives | |
MXPA04006266A (es) | Pirimidotriazinas como inhibidores de fosfatasa. | |
GEP20084376B (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
MY133112A (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use | |
SE0203070D0 (en) | Novel compounds | |
AP2001002306A0 (en) | Bridged piperazine derivatives. | |
MY133785A (en) | Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias | |
BG105688A (en) | Utilization of compounds for the prophylaxis and therapy of cerbral ischaemia | |
HK1077303A1 (en) | Hexacyclic compounds | |
EP1219296A4 (en) | SEBUM PRODUCTION INHIBITORS | |
GB9920959D0 (en) | Novel process |